Web Results

Cipher Pharmaceuticals


Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions.

Innocutis Medical, LLC: Private Company Information - Businessweek


Innocutis Medical, LLC company research & investing information. ... United States by its commercial partner, Innocutis Holdings, and the granting of a new U.S. ...

innocutis | CrunchBase


Innocutis is a pharmaceutical and medical device company developing ... Founded: 2005; Aliases: Innocutis Holdings, LLC; Employees: 1 in CrunchBase.

Innocutis Holdings LLC Licenses Sitavig from BioAlliance Pharma


Mar 19, 2014 ... Innocutis Holdings LLC is pleased to announce the licensing of Sitavig® ( ACYCLOVIR) 50mg Buccal Tablets, from BioAlliance Pharma for ...

Joe Pecora | LinkedIn


Cipher Pharmaceuticals Inc.,; Innocutis,; JSJ Pharmaceuticals. Education. University at Buffalo ... Jon Knowles. Marketing Manager at Innocutis Holdings, LLc ...

DailyMed - UMECTA PD UREA- urea emulsion


More Info For This Drug. View Label Archives; RxNorm; Get Label RSS Feed. NDC Code(s): 68712-017-01, 68712-017-02; Packager: Innocutis Holdings LLC.

Charles F. Jenkins | LinkedIn


Cipher Pharmaceuticals Inc. Previous. Innocutis Holdings, LLC,; Innocutis Medical, LLC,; Medicis. Education. University of South Carolina-Columbia. Websites.

DailyMed - UMECTA UREA- urea film


NDC Code(s): 68712-010-01, 68712-010-03, 68712-010-04; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA ...

DailyMed - UMECTA MOUSSE UREA - urea foam aerosol, foam


NDC Code(s): 68712-020-01; Packager: Innocutis Holdings LLC. Category: HUMAN PRESCRIPTION DRUG LABEL; DEA Schedule: None; Marketing Status:  ...

BioAlliance Pharma: Sitavig® Licensing Strategy | Business Wire


Mar 19, 2014 ... Execution of licensing agreement with Innocutis for North America ... with Innocutis Holding LLC to commercialize Sitavig® in North America.

More Info

Cipher Pharmaceuticals announces U.S. commercial entry through ...


Apr 13, 2015 ... ... that it has acquired INNOCUTIS Holdings LLC ("INNOCUTIS"), a privately held specialty dermatology company, for US$45.5 million in cash.

Cipher Pharmaceuticals acquires INNOCUTIS Holdings ... - Onxeo


Apr 13, 2015 ... oncology drugs, today announced Cipher Pharmaceuticals' (NASDAQ: CPHR) acquisition of INNOCUTIS. Holdings LLC, the licensee of ...

Innocutis Holdings LLC - Company Profile - BioCentury


Apr 2, 2012 ... Innocutis' detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma ...